Recently, AccuMedical's Lattice Flow Diverter was awarded the 2024 Patent-Intensive Product Recognition, granted by Patent Protection Association of China. This honor is a high recognition of AccuMedical's innovation strength in the medical device field and a strong testament to the advanced technology and uniqueness of the Lattice product.
Lattice Flow Diverter
Patent-intensive products refer to those that gain a competitive market advantage primarily from the patents they utilize. These products typically feature high patent protection strength, significant patent value contribution, and high dependence on patents for their competitiveness.
Since its development, the Lattice Flow Diverter has been dedicated to solving complex cerebrovascular diseases with its innovative design concept. Its multiple core patented technologies encompass innovations in material science, precision manufacturing processes, and more. The integration of these technologies enables the device to excel in flow diversion, vascular reconstruction, and long-term stability, providing patients with safer and more effective treatment options.
This recognition marks the Lattice Flow Diverter as a leader in intellectual property protection and technological innovation density in the industry. At the same time, this honor will inspire the company to continue increasing its research and development investment, further focusing on the medical device field, and contributing to solving more medical challenges and safeguarding human health.